Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,310.00
-100.00 (-1.19%)
At close: Jun 13, 2025, 3:30 PM KST
-22.70%
Market Cap 31.58B
Revenue (ttm) 23.41B
Net Income (ttm) -1.72B
Shares Out 3.80M
EPS (ttm) -452.27
PE Ratio n/a
Forward PE n/a
Dividend 75.00 (0.90%)
Ex-Dividend Date Dec 27, 2024
Volume 13,583
Average Volume 7,641
Open 8,410.00
Previous Close 8,410.00
Day's Range 8,270.00 - 8,410.00
52-Week Range 7,860.00 - 11,820.00
Beta 0.66
RSI 45.16
Earnings Date Aug 11, 2025

About KOSDAQ:036480

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1966
Employees 134
Stock Exchange KOSDAQ
Ticker Symbol 036480
Full Company Profile

Financial Performance

In 2024, KOSDAQ:036480's revenue was 23.80 billion, a decrease of -6.88% compared to the previous year's 25.56 billion. Losses were -1.77 billion, 160.3% more than in 2023.

Financial Statements

News

There is no news available yet.